Tournier Marie, Moride Yola, Ducruet Thierry, Moshyk Andriy, Rochon Sophie
Centre for Clinical Epidemiology and Community Studies, Sir Mortimer B. Davis (SMBD) Jewish General Hospital, Montreal, Quebec, Canada.
Acta Ophthalmol. 2008 Mar;86(2):196-201. doi: 10.1111/j.1600-0420.2007.01024.x. Epub 2007 Sep 21.
To assess the effect of visual impairment (VI) on the risk of depression or death in the community-dwelling elderly population.
A population-based, retrospective fixed cohort study was conducted in the community-dwelling elderly (age > or = 65 years) outpatient population of Quebec. The cohort was assembled through the Quebec medical services database and consisted of the 5063 patients aged > or = 65 years who received a diagnosis of VI during the years 2000-2004. The reference cohort consisted of 16 932 elderly subjects who were randomly selected among members of the public drug programme. The outcome variables were depression and death. The main independent variable was VI and covariates included age, gender, chronic disease score, fracture and diabetes.
Controlling for covariates, VI was associated with an increased risk of depression although the effect was not modified by severity (hazard ratio [HR] = 1.35, 95% confidence interval [CI] 1.10-1.66 for severe VI; HR = 1.35, 95% CI 1.09-1.69 for moderate VI). Visual impairment was associated with an increased risk of mortality; patients with moderate vision loss had a higher risk of death (HR = 1.70, 95% CI 1.55-1.87) than those with severe vision loss (HR = 1.34, 95% CI 1.21-1.48).
Given the ageing of the population, VI in elderly subjects is becoming a public health concern. These findings enhance the need to detect and treat VI in order to improve the quality of life and to prevent premature mortality in the elderly population.
评估视力障碍(VI)对社区居住老年人群发生抑郁或死亡风险的影响。
在魁北克社区居住的老年(年龄≥65岁)门诊人群中开展了一项基于人群的回顾性固定队列研究。该队列通过魁北克医疗服务数据库组建,由2000年至2004年期间接受VI诊断的5063例年龄≥65岁的患者组成。对照队列由16932名老年受试者组成,这些受试者是从公共药物项目成员中随机选取的。结局变量为抑郁和死亡。主要自变量为VI,协变量包括年龄、性别、慢性病评分、骨折和糖尿病。
在对协变量进行控制后,VI与抑郁风险增加相关,尽管该效应未因严重程度而改变(重度VI的风险比[HR]=1.35,95%置信区间[CI]为1.10 - 1.66;中度VI的HR = 1.35,95%CI为1.09 - 1.69)。视力障碍与死亡风险增加相关;中度视力丧失患者的死亡风险(HR = 1.70,95%CI为1.55 - 1.87)高于重度视力丧失患者(HR = 1.34,95%CI为1.21 - 1.48)。
鉴于人口老龄化,老年受试者的VI正成为一个公共卫生问题。这些发现强化了检测和治疗VI以改善老年人生活质量并预防过早死亡的必要性。